Drug target prioritization by perturbed gene expression and network information

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Isik, Zerrin ^a,b   Baldow, Christoph ^a   Cannistraci, Carlo Vittorio ^a   Schroeder, Michael ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; BIOLOGY; CELL LINE; DRUG DEVELOPMENT; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; HUMAN; PROCEDURES; PROTEIN PROTEIN INTERACTION; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SIGNAL TRANSDUCTION;

ALGORITHMS; CELL LINE; COMPUTATIONAL BIOLOGY; DRUG DISCOVERY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; PROTEIN INTERACTION MAPS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SIGNAL TRANSDUCTION;

EID: 84948800043     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17417     Document Type: Article

References (40)

1. Lamb, J. et al. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929-35 (2006)
2. Iskar, M. et al. Characterization of drug-induced transcriptional modules: towards drug repositioning and functional understanding. Mol Syst Biol 9, 662 (2013)
3. Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G. & Nussinov, R. Structure and dynamics of molecular networks: A novel paradigm of drug discovery: A comprehensive review, Pharmacol Ther 138, 333-408 (2013)
4. Laenen, G., Thorrez, L., Bornigen, D. & Moreau, Y. Finding the targets of a drug by integration of gene expression data with a protein interaction network. Mol BioSyst 9, 1676-85 (2013)
5. Emig, D. et al. Drug target prediction and repositioning using an integrated network-based approach. PLoS One 8, e60618 (2013)
6. Yeh, S. H., Yeh, H. Y. & Soo, V. W. A network flow approach to predict drug targets from microarray data, disease genes and interactome network-case study on prostate cancer. J Clin Bioinforma 2, 1 (2012)
7. Chen, X., Liu, M. X. & Yan, G. Y. Drug-target interaction prediction by random walk on the heterogeneous network. Mol BioSyst 8, 1970-8 (2012)
8. Li, M., Zhang, H., Wang, J. X. & Pan, Y. A new essential protein discovery method based on the integration of protein-protein interaction and gene expression data. BMC Syst Biol 6, 15 (2012)
9. Qian, P. & Nicholas, S. Utility of Network Integrity Methods in Therapeutic Target Identification. Front Genet 5, 12 (2014)
10. Kotlyar, M., Fortney, K. & Jurisica, I. Network-based characterization of drug-regulated genes, drug targets, and toxicity. Methods 57, 499-507 (2012)
11. Marton, M. J. et al. Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat Med. 4, 1293-301 (1998)
12. Koschützki, D. & Schreiber, F. Centrality Analysis Methods for Biological Networks and Their Application to Gene Regulatory Networks. Gene Regul Syst Bio 2, 193-201 (2008)
13. Kuhn, M. et al. Stitch 3: zooming in on protein-chemical interactions. Nucleic Acids Res 40, D876-80 (2012)
14. Bauer-Mehren, A., Furlong, L. I. & Sanz, F. Pathway databases and tools for their exploitation: benefits, current limitations and challenges. Mol Syst Biol 5, 290 (2009)
15. Yang, F. et al. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res 65, 8887-95 (2005)
16. Fu, M. et al. Peroxisome proliferator-activated receptor gamma inhibits transforming growth factor beta-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with smad3. J Biol Chem 276, 45888-94 (2001)
17. Reka, A. K. et al. Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing smad3- mediated epithelial-mesenchymal transition. Mol Cancer Ther 9, 3221-32 (2010)
18. Hirsch, J. et al. Pedf inhibits il8 production in prostate cancer cells through pedf receptor / phospholipase a2 and regulation of nfb and ppar. Cytokine 55, 202-10 (2011)
19. Das, R., Hammamieh, R., Neill, R., Melhem, M. & Jett, M. Expression pattern of fatty acid binding proteins in human normal and cancer prostate cells and tissues. Clin Cancer Res 7, 1706-15 (2001)
20. Toelle, A., Suhail, S., Jung, M., Jung, K. & Stephan, C. Fatty acid binding proteins (fabps) in prostate, bladder and kidney cancer cell lines and the use of il-fabp as survival predictor in patients with renal cell carcinoma. BMC Cancer 11, 302 (2011)
21. Wang, J. et al. Prognostic value and function of klf4 in prostate cancer: Rnaa and vector-mediated overexpression identify klf4 as an inhibitor of tumor cell growth and migration. Cancer Res 70, 10182-91 (2010)
22. Li, S., Zhou, Q., He, H., Zhao, Y. & Liu, Z. Peroxisome proliferator-activated receptor agonists induce cell cycle arrest through transcriptional regulation of kruppel-like factor 4 (klf4). J Biol Chem 288, 4076-84 (2013)
23. Stumpf, M. P. H. et al. Estimating the size of the human interactome. Proc Natl Acad Sci 105, 6959-64 (2008)
24. Aranda, B. et al. PSICQUIC and PSISCORE: accessing and scoring molecular interactions, Nat Methods 8, 528-29 (2011)
25. Gitter, A., Klein-Seetharaman, J., Gupta, A. & Bar-Joseph, Z. Discovering pathways by orienting edges in protein interaction networks. Nucleic Acids Res 39, e22 (2011)
26. Zhu, J. et al. Integrating large-scale functional genomic data to dissect the complexity of yeast regulatory networks. Nat Genet 40, 854-61 (2008)
27. Barshir, R. et al. The TissueNet database of human tissue protein-protein interactions. Nucleic Acids Res 41, D841-4 (2013)
28. Schaefer, M. H. et al. Adding protein context to the human protein-protein interaction network to reveal meaningful interactions. PLoS Comput Biol 9, e1002860 (2013)
29. Govanni, M., Alfredo, F., Alfredo, P. & Rosalba, G. SPECTRA: an Integrated Knowledge Base for Comparing Tissue and Tumor Specific PPI Networks in Human. Front Bioeng Biotech 3, 58 (2015)
30. Irizarry, R. E. et al. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31, e15 (2003)
31. Franceschini, A. et al. String v9. 1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 41, D808-15 (2013)
32. Daminelli, S., Haupt, V. J., Reimann, M. & Schroeder, M. Drug repositioning through incomplete bi-cliques in an integrated drug-target-disease network. Integr Biol (Camb) 4, 778-88 (2012)
33. Berman, H. M. et al. The protein data bank. Nucleic Acids Res 28, 235-42 (2000)
34. Zhu, F. et al. Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res 40, D1128-36 (2012)
35. Liu, T., Lin, Y., Wen, X., Jorissen, R. N. & Gilson, M. K. Bindingdb: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res 35, D198-201 (2007)
36. Haupt, V. J., Daminelli, S. & Schroeder, M. Drug promiscuity in pdb: Protein binding site similarity is key. PLoS One 8, e65894 (2013)
37. Peng, W. et al. Iteration method for predicting essential proteins based on orthology and protein-protein interaction networks. BMC Syst Biol 6, 87 (2012)
38. Cannistraci, C. V., Alanis-Lobato, G. & Ravasi, T. From link-prediction in brain connectomes and protein interactomes to the local-community-paradigm in complex networks. Sci Rep 3, 1613 (2013)
39. Fawcett, T. An introduction to ROC analysis. Pattern Recogn Lett 27, 861-74 (2006)
40. Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13, 2498-504 (2003)